These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 12664309

  • 1. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [Abstract] [Full Text] [Related]

  • 2. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].
    Broich K.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064
    [Abstract] [Full Text] [Related]

  • 3. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA, Hinterhuber H.
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [Abstract] [Full Text] [Related]

  • 4. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ, Ryan ND, Wagner KD.
    J Clin Psychiatry; 2005 May; 66 Suppl 7():14-20. PubMed ID: 16124837
    [Abstract] [Full Text] [Related]

  • 5. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A, Brodhead AE, Kolts RL, Brown WA.
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [Abstract] [Full Text] [Related]

  • 6. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RL.
    J Clin Oncol; 2008 Mar 10; 26(8):1371-8. PubMed ID: 18227527
    [Abstract] [Full Text] [Related]

  • 7. Ethical issues of placebo-controlled studies in depression and a randomized withdrawal trial in Japan: case study in the ethics of mental health research.
    Tashiro S, Yamada MM, Matsui K.
    J Nerv Ment Dis; 2012 Mar 10; 200(3):255-9. PubMed ID: 22373766
    [Abstract] [Full Text] [Related]

  • 8. The persistence of the placebo response in antidepressant clinical trials.
    Khan A, Redding N, Brown WA.
    J Psychiatr Res; 2008 Aug 10; 42(10):791-6. PubMed ID: 18036616
    [Abstract] [Full Text] [Related]

  • 9. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB, Massaro JM, Sullivan LM.
    Stat Med; 2003 Jan 30; 22(2):169-86. PubMed ID: 12520555
    [Abstract] [Full Text] [Related]

  • 10. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A, Goldsmith C.
    Lancet; 2003 Dec 20; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract] [Full Text] [Related]

  • 11. The ethics of placebo-controlled trials: the case of asthma.
    Onder RF.
    J Allergy Clin Immunol; 2005 Jun 20; 115(6):1228-34. PubMed ID: 15940139
    [Abstract] [Full Text] [Related]

  • 12. How should efficacy be evaluated in randomized clinical trials of treatments for depression?
    Thase ME.
    J Clin Psychiatry; 1999 Jun 20; 60 Suppl 4():23-31; discussion 32. PubMed ID: 10086480
    [Abstract] [Full Text] [Related]

  • 13. Who should receive antidepressants: suggestions from placebo treatment.
    Khan A, Brown WA.
    Psychopharmacol Bull; 1991 Jun 20; 27(3):271-4. PubMed ID: 1775597
    [Abstract] [Full Text] [Related]

  • 14. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC.
    J Clin Psychiatry; 2004 Jun 20; 65 Suppl 4():31-6. PubMed ID: 15046539
    [Abstract] [Full Text] [Related]

  • 15. Placebo response and antidepressant clinical trial outcome.
    Khan A, Detke M, Khan SR, Mallinckrodt C.
    J Nerv Ment Dis; 2003 Apr 20; 191(4):211-8. PubMed ID: 12695731
    [Abstract] [Full Text] [Related]

  • 16. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
    Temple R, Ellenberg SS.
    Ann Intern Med; 2000 Sep 19; 133(6):455-63. PubMed ID: 10975964
    [Abstract] [Full Text] [Related]

  • 17. Impact of study design on the results of continuation studies of antidepressants.
    Zimmerman M, Posternak MA, Ruggero CJ.
    J Clin Psychopharmacol; 2007 Apr 19; 27(2):177-81. PubMed ID: 17414242
    [Abstract] [Full Text] [Related]

  • 18. The future of psychopharmacology of depression.
    Chang T, Fava M.
    J Clin Psychiatry; 2010 Aug 19; 71(8):971-5. PubMed ID: 20797377
    [Abstract] [Full Text] [Related]

  • 19. [The relationship between the placebo effect and spontaneous improvement in research on antidepressants. Are placebos powerless?].
    Hougaard E.
    Ugeskr Laeger; 2005 Aug 08; 167(32):2865-9. PubMed ID: 16109187
    [Abstract] [Full Text] [Related]

  • 20. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF, Hughes JG, Hiscock JJ, Wigglesworth M, Walley TJ.
    BMC Health Serv Res; 2007 Apr 30; 7():64. PubMed ID: 17470280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.